We are live on
!
Find out more
Lazard Asset Management Portfolio holdings
AUM
$60.8B
1-Year Est. Return
22.47%
This Fund
S&P 500
This Quarter
Est. Return
+0.1%
1 Year Est. Return
+22.47%
3 Year Est. Return
+62.53%
5 Year Est. Return
+77.87%
10 Year Est. Return
+305.76%
AUM
$68.4B
AUM Growth
-$6.42B
(-8.6%)
Cap. Flow
-$9.95B
Cap. Flow
% of AUM
-14.55%
Top 10 Holdings %
Top 10 Hldgs %
25.74%
Holding
2,605
New
281
Increased
825
Reduced
894
Closed
234
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$433M |
| 2 |
Merck
MRK
|
+$286M |
| 3 |
Jacobs Solutions
J
|
+$265M |
| 4 |
Equifax
EFX
|
+$253M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$240M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$710M |
| 2 |
Johnson & Johnson
JNJ
|
+$574M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$480M |
| 4 |
Marvell Technology
MRVL
|
+$377M |
| 5 |
Wells Fargo
WFC
|
+$333M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.04% |
| 2 | Financials | 14.64% |
| 3 | Healthcare | 12% |
| 4 | Industrials | 10.54% |
| 5 | Consumer Discretionary | 9.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1801
AeroVironment
AVAV
$8.51B
| $47K | ﹤0.01% |
310
-582
| -65% | -$114K |
|
1802
Rocky Brands
RCKY
$374M
| $47K | ﹤0.01% |
2,089
-12,167
| -85% | -$298K |
|
|
SGMO
1803
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $47K | ﹤0.01% |
+46,463
| New | +$84.9K |
|
|
SOR
1804
Source Capital
SOR
$383M
| $47K | ﹤0.01% |
1,087
| – | – |
|
1805
Trustmark
TRMK
$2.83B
| $47K | ﹤0.01% |
+1,344
| New | +$48.5K |
|
|
XHR
1806
Xenia Hotels & Resorts
XHR
$1.89B
| $47K | ﹤0.01% |
+3,210
| New | +$48.6K |
|
1807
BancFirst
BANF
$3.83B
| $46K | ﹤0.01% |
396
-2,180
| -85% | -$256K |
|
1808
Digi International
DGII
$2.74B
| $45K | ﹤0.01% |
+1,494
| New | +$46.6K |
|
1809
Five Point Holdings
FPH
$371M
| $45K | ﹤0.01% |
+11,922
| New | +$46.7K |
|
1810
Healthcare Realty
HR
$6.99B
| $45K | ﹤0.01% |
+2,679
| New | +$47.1K |
|
1811
Macerich
MAC
$7.2B
| $45K | ﹤0.01% |
+2,298
| New | +$44.9K |
|
1812
Orthofix Medical
OFIX
$421M
| $45K | ﹤0.01% |
+2,596
| New | +$45.1K |
|
|
ONL
1813
Orion Office REIT
ONL
$154M
| $45K | ﹤0.01% |
+12,285
| New | +$48.3K |
|
1814
Packaging Corp of America
PKG
$22.8B
| $45K | ﹤0.01% |
204
+186
| +1,033% | +$43K |
|
|
BWAY
1815
Brainsway
BWAY
$602M
| $44K | ﹤0.01% |
+9,354
| New | +$45.5K |
|
1816
Cushman & Wakefield Ltd
CWK
$3.29B
| $44K | ﹤0.01% |
3,406
-287
| -8% | -$3.99K |
|
1817
NatWest
NWG
$76.5B
| $44K | ﹤0.01% |
+4,361
| New | +$43.2K |
|
|
VRN
1818
DELISTED
Veren
VRN
| $44K | ﹤0.01% |
8,714
-547
| -6% | -$3K |
|
1819
AMERISAFE
AMSF
$553M
| $43K | ﹤0.01% |
+851
| New | +$46.1K |
|
1820
Edgewell Personal Care
EPC
$1.35B
| $43K | ﹤0.01% |
1,306
-17,858
| -93% | -$631K |
|
1821
Gogo Inc
GOGO
$603M
| $43K | ﹤0.01% |
+5,437
| New | +$40.5K |
|
1822
Mettler-Toledo International
MTD
$28.5B
| $43K | ﹤0.01% |
36
-1,004
| -97% | -$1.31M |
|
1823
Saic
SAIC
$5.09B
| $43K | ﹤0.01% |
385
-32
| -8% | -$4.22K |
|
|
XIFR
1824
XPLR Infrastructure LP
XIFR
$1.09B
| $43K | ﹤0.01% |
2,469
+1,430
| +138% | +$28.5K |
|
1825
General Dynamics
GD
$104B
| $42K | ﹤0.01% |
162
-4
| -2% | -$1.15K |
|
Similar funds
QCM
Lazard Asset Management's Q4 2024 Portfolio in Review
As of Q4 2024, Lazard Asset Management held 2,605 positions worth $68.4B, down 8.6% from $74.8B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Lazard Asset Management withdrew a net $9.95B in Q4 2024, closing 234 positions and reducing 894 holdings. Its most notable exit was Atlantica Sustainable Infrastructure plc Ordinary Shares, an estimated $210M position sold in full.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Lazard Asset Management opened a new position in Vaxcyte worth $39.8M.
- Lazard Asset Management's largest Q4 2024 buy was Vaxcyte: 486,764 shares worth $39.8M.
- Lazard Asset Management added most to Eli Lilly in Q4 2024, an estimated $433M increase.
- Lazard Asset Management's biggest Q4 2024 reduction was Microsoft, cutting an estimated $710M.
- Lazard Asset Management fully exited Atlantica Sustainable Infrastructure plc Ordinary Shares in Q4 2024, selling an estimated $210M.
- Lazard Asset Management's ten largest holdings make up 26% of its $68.4B portfolio in Q4 2024.
- Lazard Asset Management opened 281 new positions and closed 234 in Q4 2024.
- Lazard Asset Management's portfolio value fell 8.6% quarter-over-quarter to $68.4B.
Based on Lazard Asset Management's 13F filing for Q4 2024, filed 14 Feb 2025.